Literature DB >> 8649789

The identification of p130cas-binding proteins and their role in cellular transformation.

M R Burnham1, M T Harte, A Richardson, J T Parsons, A H Bouton.   

Abstract

Adaptor proteins play an important role in signal transduction by regulating the establishment and maintenance of functionally important protein complexes. A recently described member of this group of proteins is p130cas (CAS), which contains numerous sequence motifs predicted to be involved in mediating protein-protein interactions. We propose that adaptor molecules like CAS may help determine the response of a cell to a particular signal by interacting with specific subsets of cellular proteins. To test this hypothesis, we have identified potential binding partners of CAS that may play a rote in cellular transformation by the oncoproteins v-SRC and/or v-CRK. We show that individual domains of CAS associate with specific subsets of proteins in vitro, and that many of these interactions are dependent on the state of tyrosine-phosphorylation of CAS. Sequences necessary for interacting with the focal adhesion kinase pp125FAK (FAK), v-SRC and v-CRK have been mapped to distinct regions of CAS. In addition, the identification of a number of putative CAS-binding partners that are present in crk-transformed cell extracts but undetectable in normal and src-transformed cell extracts supports a model in which unique protein complexes are formed in response to different signals.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8649789

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  26 in total

Review 1.  Focal adhesion kinases: interest in immunoendocrinology, developmental biology, and cancer.

Authors:  H J Martens; V Geenen
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

2.  CMS: an adapter molecule involved in cytoskeletal rearrangements.

Authors:  K H Kirsch; M M Georgescu; S Ishimaru; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

3.  Adenovirus protein VII condenses DNA, represses transcription, and associates with transcriptional activator E1A.

Authors:  Jeffrey S Johnson; Yvonne N Osheim; Yuming Xue; Margaux R Emanuel; Peter W Lewis; Alex Bankovich; Ann L Beyer; Daniel A Engel
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

4.  Adenovirus protein VII functions throughout early phase and interacts with cellular proteins SET and pp32.

Authors:  Yuming Xue; Jeffrey S Johnson; David A Ornelles; Judy Lieberman; Daniel A Engel
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

5.  Src phosphorylates Cas on tyrosine 253 to promote migration of transformed cells.

Authors:  Gary S Goldberg; David B Alexander; Patricia Pellicena; Zhong-Yin Zhang; Hiroyuki Tsuda; W Todd Miller
Journal:  J Biol Chem       Date:  2003-09-11       Impact factor: 5.157

Review 6.  Bidirectional signaling between Yersinia and its target cell.

Authors:  M Fällman; C Persson; K Schesser; H Wolf-Watz
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

7.  Cell cycle-regulated processing of HEF1 to multiple protein forms differentially targeted to multiple subcellular compartments.

Authors:  S F Law; Y Z Zhang; A J Klein-Szanto; E A Golemis
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

Review 8.  Yersinia proteins that target host cell signaling pathways.

Authors:  M Fällman; C Persson; H Wolf-Watz
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

9.  Mechanisms of CAS substrate domain tyrosine phosphorylation by FAK and Src.

Authors:  P J Ruest; N Y Shin; T R Polte; X Zhang; S K Hanks
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

10.  p130Cas mediates the transforming properties of the anaplastic lymphoma kinase.

Authors:  Chiara Ambrogio; Claudia Voena; Andrea D Manazza; Roberto Piva; Ludovica Riera; Laura Barberis; Carlotta Costa; Guido Tarone; Paola Defilippi; Emilio Hirsch; Elisabetta Boeri Erba; Shabaz Mohammed; Ole N Jensen; Giorgio Palestro; Giorgio Inghirami; Roberto Chiarle
Journal:  Blood       Date:  2005-08-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.